135 related articles for article (PubMed ID: 38187938)
1. Carbetocin as a uterotonic in a parturient with a Fontan circulation.
Saadat F; Dob DP; Cox ML; Johnson MR; Gatzoulis MA
Anaesth Rep; 2024; 12(1):e12272. PubMed ID: 38187938
[No Abstract] [Full Text] [Related]
2. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
Gallos I; Williams H; Price M; Pickering K; Merriel A; Tobias A; Lissauer D; Gee H; Tunçalp Ö; Gyte G; Moorthy V; Roberts T; Deeks J; Hofmeyr J; Gülmezoglu M; Coomarasamy A
Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of carbetocin in the prevention of postpartum hemorrhage: a systematic review and Bayesian meta-analysis of randomized trials.
Kalafat E; Gokce A; O'Brien P; Benlioglu C; Koc A; Karaaslan O; Khalil A
J Matern Fetal Neonatal Med; 2021 Jul; 34(14):2303-2316. PubMed ID: 31537134
[TBL] [Abstract][Full Text] [Related]
4. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID; Williams HM; Price MJ; Merriel A; Gee H; Lissauer D; Moorthy V; Tobias A; Deeks JJ; Widmer M; Tunçalp Ö; Gülmezoglu AM; Hofmeyr GJ; Coomarasamy A
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011689. PubMed ID: 29693726
[TBL] [Abstract][Full Text] [Related]
5. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID; Papadopoulou A; Man R; Athanasopoulos N; Tobias A; Price MJ; Williams MJ; Diaz V; Pasquale J; Chamillard M; Widmer M; Tunçalp Ö; Hofmeyr GJ; Althabe F; Gülmezoglu AM; Vogel JP; Oladapo OT; Coomarasamy A
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011689. PubMed ID: 30569545
[TBL] [Abstract][Full Text] [Related]
6. Carbetocin for the prevention of postpartum hemorrhage: a systematic review and meta-analysis of randomized controlled trials.
Jin B; Du Y; Zhang F; Zhang K; Wang L; Cui L
J Matern Fetal Neonatal Med; 2016; 29(3):400-7. PubMed ID: 25579116
[TBL] [Abstract][Full Text] [Related]
7. The maternal cardiovascular effect of carbetocin compared to oxytocin in women undergoing caesarean section.
Pisani I; Tiralongo GM; Gagliardi G; Scala RL; Todde C; Frigo MG; Valensise H
Pregnancy Hypertens; 2012 Apr; 2(2):139-42. PubMed ID: 26105099
[TBL] [Abstract][Full Text] [Related]
8. Carbetocin for preventing postpartum haemorrhage.
Su LL; Chong YS; Samuel M
Cochrane Database Syst Rev; 2012 Apr; (4):CD005457. PubMed ID: 22513931
[TBL] [Abstract][Full Text] [Related]
9. Carbetocin for preventing postpartum haemorrhage.
Su LL; Chong YS; Samuel M
Cochrane Database Syst Rev; 2012 Feb; (2):CD005457. PubMed ID: 22336812
[TBL] [Abstract][Full Text] [Related]
10. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin.
Rath W
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):15-20. PubMed ID: 19616358
[TBL] [Abstract][Full Text] [Related]
11. Carbetocin compared to oxytocin in emergency cesarean section: a randomized trial.
Razali N; Md Latar IL; Chan YK; Omar SZ; Tan PC
Eur J Obstet Gynecol Reprod Biol; 2016 Mar; 198():35-39. PubMed ID: 26773246
[TBL] [Abstract][Full Text] [Related]
12. Carbetocin versus oxytocin in caesarean section with high risk of post-partum haemorrhage.
Larciprete G; Montagnoli C; Frigo M; Panetta V; Todde C; Zuppani B; Centonze C; Bompiani A; Malandrenis I; Cirese A; Valensise H
J Prenat Med; 2013 Jan; 7(1):12-8. PubMed ID: 23741542
[TBL] [Abstract][Full Text] [Related]
13. Uncontrolled before-after study adding carbetocin in addition to oxytocin decreases blood loss for cesarean section in twin pregnancies.
Hsu WW; Chen HY; Lin SY; Tai YY; Kang J; Lin MW; Lee CN
J Formos Med Assoc; 2021 Aug; 120(8):1635-1641. PubMed ID: 33581963
[TBL] [Abstract][Full Text] [Related]
14. Oxytocin agonists for preventing postpartum haemorrhage.
Su LL; Chong YS; Samuel M
Cochrane Database Syst Rev; 2007 Jul; (3):CD005457. PubMed ID: 17636798
[TBL] [Abstract][Full Text] [Related]
15. Heat stable carbetocin vs. oxytocin for the prevention of post-partum hemorrhage in emergency caesarean delivery: a randomized controlled trial.
Al Zubaidi S; Alhaidari T
J Perinat Med; 2022 Feb; 50(2):150-156. PubMed ID: 34535047
[TBL] [Abstract][Full Text] [Related]
16. Uterotonic drug usage in Canada: a snapshot of the practice in obstetric units of university-affiliated hospitals.
Thorneloe B; Carvalho JCA; Downey K; Balki M
Int J Obstet Anesth; 2019 Feb; 37():45-51. PubMed ID: 30396679
[TBL] [Abstract][Full Text] [Related]
17. Intramuscular oxytocin versus Syntometrine
van der Nelson H; O'Brien S; Burnard S; Mayer M; Alvarez M; Knowlden J; Winter C; Dailami N; Marques E; Burden C; Siassakos D; Draycott T
BJOG; 2021 Jun; 128(7):1236-1246. PubMed ID: 33300296
[TBL] [Abstract][Full Text] [Related]
18. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
Borruto F; Treisser A; Comparetto C
Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
[TBL] [Abstract][Full Text] [Related]
19. Carbetocin: Worth the extra expense?
Gallos ID; Coomarasamy A
Best Pract Res Clin Obstet Gynaecol; 2019 Nov; 61():55-65. PubMed ID: 31164260
[TBL] [Abstract][Full Text] [Related]
20. Uterotonic Drugs for the Prevention of Postpartum Haemorrhage: A Cost-Effectiveness Analysis.
Pickering K; Gallos ID; Williams H; Price MJ; Merriel A; Lissauer D; Tobias A; Hofmeyr GJ; Coomarasamy A; Roberts TE
Pharmacoecon Open; 2019 Jun; 3(2):163-176. PubMed ID: 30506157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
